MiMedx Group Q1 2024 Adj EPS $0.07 Beats $0.04 Estimate, Sales $84.709M Beat $79.361M Estimate
MiMedx Group Q1 2024 Adj EPS $0.07 Beats $0.04 Estimate, Sales $84.709M Beat $79.361M Estimate
MimedX集团2024年第一季度调整后每股收益0.07美元超过预期的0.04美元，销售额8,4709万美元超过7,9361万美元的预期
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 percent. This is a 333.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $84.709 million which beat the analyst consensus estimate of $79.361 million by 6.74 percent. This is a 18.18 percent increase over sales of $71.676 million the same period last year.
MimedX集团（纳斯达克股票代码：MDXG）公布的季度收益为每股0.07美元，比分析师普遍预期的0.04美元高出75％。与去年同期每股亏损0.03美元（0.03）相比，增长了333.33％。该公司公布的季度销售额为8,4709万美元，比分析师普遍预期的7,936.1万美元高出6.74％。这比去年同期的7167.6万美元的销售额增长了18.18％。